People: Fresenius Medical Care AG & Co KGaA (FMEG.DE)

FMEG.DE on Xetra

50.13EUR
25 Jul 2014
Price Change (% chg)

€-0.24 (-0.48%)
Prev Close
€50.37
Open
€50.20
Day's High
€50.37
Day's Low
€49.94
Volume
593,486
Avg. Vol
752,526
52-wk High
€54.32
52-wk Low
€46.51

Search Stocks

Summary

Name Age Since Current Position

Gerd Krick

1998 Chairman of the Supervisory Board

Rice Powell

2013 Chairman of the Management Board, Chief Executive Officer

Ben Lipps

2013 Honorary Chairman

Dieter Schenk

1996 Vice Chairman of the Supervisory Board

Michael Brosnan

2010 Chief Financial Officer, Member of the Management Board

Oliver Maier

Senior Vice President of Investor Relations

Roberto Fuste

1999 Member of the Management Board for Asia-Pacific

Ronald Kuerbitz

2012 Member of the Management Board for North America

Olaf Schermeier

2013 Member of the Management Board for Global Research & Development

Kent Wanzek

2010 Member of the Management Board, Global Products Manufacturing Operations

Dominik Wehner

2014 Member of the Management Board for Europe, Middle East and Africa

Rolf Classon

69 2011 Member of the Supervisory Board

Bernd Fahrholz

1998 Member of the Supervisory Board

William Johnston

2006 Member of the Supervisory Board

Walter Weisman

1996 Member of the Supervisory Board

Biographies

Name Description

Gerd Krick

Dr. Gerd Krick has been Chairman of the Supervisory Board at Fresenius Medical Care AG & Co KGaA since January 1, 1998. Additionally, Dr. Krick acts as Member of the Audit and Corporate Governance Committee, as well as Chairman of the Nominating Committee at the Company. He was Chairman of the Fresenius AG Management Board from 1992 to May 2003 at which time he became Chairman of the Supervisory Board. Prior to 1992, he was a Director of the Medical Systems Division of Fresenius AG and Deputy Chairman of the Fresenius AG Management Board. From September 1996 until December 1997, Dr. Krick was Chairman of the Management Board of Fresenius Medical Care. Dr. Krick was Member of the Advisory Board of HDI V.a.G until December 31, 2008, and Member of the Supervisory Board of Allianz Private Kankenversicherungs-AG until April 16, 2008. He acted as Chairman of the Supervisory Board of Fresenius SE until January 28, 2011. He is Chairman of the Supervisory Board of VAMED AG, Member of the Supervisory Board at Fresenius Medical Care Management AG. He has acted as Member of the Supervisory Board at Fresenius Management SE since March 11, 2010 and since May 12, 2010 as its Chairman.

Rice Powell

Mr. Rice Powell has been appointed Chief Executive Officer and Chairman of the Management Board at Fresenius Medical Care AG & Co KGaA effective January 1, 2013. Prior to that, he served as Deputy Chairman of the Management Board at the Company and Chief Executive Officer of Fresenius Medical Care North America from January 1, 2010. Previously he acted as Member of the Management Board of Fresenius Medical Care AG & Co. KGaA, CEO of Renal Therapy Group of Fresenius Medical Care in North America. He has been representative of Fresenius Medical Care Management AG, general partner of the Company. He joined Fresenius Medical Care in 1997 and was appointed co-CEO and Member of the Management Board of Fresenius Medical Care North America in January 2004. Mr. Powell has experience in the healthcare industry. From 1978 to 1996 he held various positions within Baxter International Inc, Biogen Inc, and Ergo Sciences Inc, the United States, among others.

Ben Lipps

Dr. Ben J. Lipps has been appointed Honorary Chairman of Fresenius Medical Care AG & Co KGaA effective January 1, 2013. After earning his Master and Doctoral degrees at the Massachusetts Institute of Technology in Chemical Engineering, Dr. Lipps led the research team that developed the first commercial Hollow Fiber Artificial Kidney at the end of the 1960s at DOW Chemical. Dr. Lipps has held the position of Chairman of the Management Board of Fresenius Medical Care Holdings Inc., USA and Member of the Management Board of Fresenius Management SE. He has also acted as Member of the Board of Vifor Fresenius Medical Care Renal Pharma Ltd.

Dieter Schenk

Dr. Dieter Schenk has been Vice Chairman of the Supervisory Board of Fresenius Medical Care AG & Co KGaA since 1996. He is Member of the Nominating Committee at the Company. He is an attorney and tax advisor and has been a partner in the law firm of Noerr Stiefenhofer Lutz since 1986. Dr. Schenk occupied the position of Vice Chairman of the Supervisory Board at Fresenius SE until January 28, 2011. He acts as Vice Chairman of the Supervisory Board at Fresenius Medical Care Management AG and Greiffenberger AG. He is Chairman of the Supervisory Board of TOPTICA Photonics AG, as well as Gabor Shoes AG. In addition, he has held the position of Fresenius Management SE since March 11, 2011, and since May 12, 2010 the position of Deputy Chairman of its Supervisory Board. Dr. Schenk also acts as Member of the Board of Directors of Else-Kroener-Fresenius-Striftung.

Michael Brosnan

Mr. Michael Brosnan has been Chief Financial Officer and Member of the Management Board at Fresenius Medical Care AG & Co KGaA since January 1, 2010. For the past seven years, he has served as Chief Financial Officer and Member of the Board of Directors of Fresenius Medical Care North America. Mr. Brosnan joined the Company in 1998 as Vice President of Finance and Administration for Spectra Renal Management, the Company’s laboratory services organization. Since then, he has held several executive positions in North America. Prior to joining Fresenius Medical Care, Mr. Brosnan held senior financial positions at Polaroid Corporation and was an Audit Partner at KPMG.

Oliver Maier

Roberto Fuste

Mr. Roberto Fuste has been Member of the Management Board for Asia-Pacific of Fresenius Medical Care AG & Co KGaA since January 1, 1999. After finishing his studies in economic sciences at the University of Valencia, he founded the company Nephrocontrol SA in 1983. In 1991, Nephrocontrol was acquired by the Fresenius Group, where Mr. Fuste has worked since. Before being appointed to the Management Board of Fresenius Medical Care in 1999, Mr. Fuste held several senior positions within the company in the Latin America and the Asia-Pacific region.

Ronald Kuerbitz

Mr. Ronald (Ron) Kuerbitz has been appointed Member of the Management Board for North America of Fresenius Medical Care AG & Co KGaA since January 1, 2012. He joined Fresenius Medical Care in 1997 to lead its corporate development function and was later named as Fresenius Medical Care North America's General Counsel and Chief Administrative Officer. Mr. Kuerbitz has 20 years of experience in the health care field, having held positions in law, compliance, business development, government affairs and operations. Since 2011 Mr. Kuerbitz has served as Chairman of Kidney Care Partners in Washington D.C., a coalition of patient advocates, dialysis doctors, care providers and device and pharmaceutical manufacturers working together to improve the quality of care for individuals with chronic kidney disease. Mr. Kuerbitz is a graduate of Albion College and received his juris doctor degree from the Yale Law School.

Olaf Schermeier

Dr. Olaf Schermeier is Member of the Management Board for Global Research & Development at Fresenius Medical Care AG & Co KGaA since March 1, 2013. Previously, he served as president of global R&D for Draeger Medical, Luebeck, Germany. Dr. Schermeier has many years of experience in various areas of the health care industry, among others at Charite-clinic and Biotronik, Germany. He holds a doctorate degree (PhD) in Computer Science from the Technical University of Berlin (Technische Universitaet Berlin) and graduated from the University of Hannover (Gottfried Wilhelm Leibniz Universitaet) in Electrical Engineering.

Kent Wanzek

Mr. Kent Wanzek has been Member of the Management Board, Global Products Manufacturing Operations at Fresenius Medical Care AG & Co KGaA since January 1, 2010. He has been the President for Operations of the Renal Therapies Group at Fresenius Medical Care North America since 2006. Prior to joining the Company in 2003, Mr. Wanzek had several senior executive positions including Philips Medical Systems and Baxter Healthcare Corporation.

Dominik Wehner

Mr. Dominik Wehner is Member of the Management Board for Europe, Middle East and Africa at Fresenius Medical Care AG & Co KgaA, effective April 1, 2014. He is responsible for the Europe, Middle East and Africa regions within the Company. He began his career at Fresenius Medical Care in 1994 as Sales Manager and has been currently Executive Vice President responsible for the regions of Eastern Europe, Middle East and Africa which he turned into one of the growth drivers of EMEALA. He also serves on the Vifor Fresenius Medical Care Renal Pharma Board of Directors and was instrumental in the extension of the venture activities in EMEALA.

Rolf Classon

Mr. Rolf A. Classon has been Member of the Supervisory Board at Fresenius Medical Care AG & Co KGaA since May 11, 2011. He is Chairman of the Board of Directors of Hill-Rom Holdings, Inc. (previously Hillenbrand Industries, Inc.) He is also Member of the Supervisory Board at Fresenius Medical Care Management AG since July 7, 2011. Moreover, he serves as Chairman of the Board of Directors at Auxilium Pharmaceuticals, Inc. and at Tecan Group Ltd.

Bernd Fahrholz

Prof. Dr. Bernd Fahrholz has been Member of the Supervisory Board of Fresenius Medical Care AG & Co KGaA since 1998. Additonally, he acts as Member of the Audit and Corporate Governance Committee of the Company. He serves as Chairman of the Supervisory Board of SMARTRAC N.V. He is an attorney and has been a partner in the law firm of Noerr Stiefenhofer Lutz since 2004. Prof. Dr. Fahrholz was Member of the Management Board of Dresdner Bank AG from 1998 and was Chairman from April 2000 until he resigned in March of 2003. He also served as Deputy Chairman of the Management Board of Allianz AG and Chairman of the Supervisory Board of Advance Holding AG until March 25, 2003. Prof. Dr. Fahrholz served on the Supervisory Board of BMW AG until May 13, 2004 and Heidelberg Cement AG until May 6, 2004.

William Johnston

Dr. William P. Johnston has been Member of the Supervisory Board at Fresenius Medical Care AG & Co KGaA since May 9, 2006. Additionally, he acts as Member of the Audit and Corporate Governance Committee at the Company. Dr. Johnston is former Chairman of the Board of Directors of Renal Care Group, Inc. He is also a Member of the Supervisory Board of Fresenius Medical Care Management AG. In February 2008, he was appointed as Member of the Board of Directors of HCA-Manor Care, Inc. He also acts as Member of the Board of Directors of The Hartford Mutual Funds, Inc., LifeCare Holdings, Inc., Georgia O'Keeffe Museum. He acted as Member of the Board of Directors of Multiplan Inc. until August 31, 2010.

Walter Weisman

Dr. Walter (Wally) L. Weisman has been Member of the Supervisory Board at Fresenius Medical Care AG & Co KGaA since 1996. Additionally, he acts as Chairman of the Audit and Corporate Governance Committee, as well as Member of the Nominating Committee of the Company. He is a private investor and a former Chairman and Chief Executive Officer of American Medical International, Inc. Dr. Weisman is Member of the Management Board of Occidental Petroleum Corporation. He also acts as Member of the Supervisory Board of Fresenius Medical Care Management AG. He is Deputy Chairman of the Board of Trustees for the California Institute of Technology, a trustee of the Board of Trustees of the Los Angeles County Museum of Art, Chairman of the Board of Trustees of the Sundance Institute. Dr. Weisman was Vice Chairman and Lead Director of Maguire Properties, Inc. until September 1, 2008 and was Vice Chairman of the Board of Trustees of the Samuel H. Kess Foundatuon until 1, 2008.

Basic Compensation

Name Fiscal Year Total

Gerd Krick

125,000

Rice Powell

2,507,000

Ben Lipps

4,862,000

Dieter Schenk

45,000

Michael Brosnan

1,429,000

Oliver Maier

--

Roberto Fuste

1,672,000

Ronald Kuerbitz

1,787,000

Olaf Schermeier

1,028,000

Kent Wanzek

1,299,000

Dominik Wehner

--

Rolf Classon

30,000

Bernd Fahrholz

98,000

William Johnston

65,000

Walter Weisman

80,000
As Of 30 Dec 2013
Search Stocks